Home

Bioworkshops sell "Omalizumab"

Basic Information

1.0K
48
22
4.1(46)

Trade Type

Sell

Product Name

Omalizumab

Manufacturer(s)

Specifications

  • Expression System: Optimized mammalian cell line supported by a Drug Master File (DMF) filing, delivering consistently high titers for cost-efficient large-scale manufacturing.
  • Regulatory Status: Cell line developed for global regulatory readiness (DMF filing) supporting this IgE-directed antibody biosimilar (reference product first approved 2002-06-13, Australia).
  • Application: IgE-directed antibody biosimilar for immune, respiratory and skin/musculoskeletal diseases, including allergic asthma, chronic rhinosinusitis with nasal polyps, and chronic urticaria.
  • Purity: Proven high degree of analytical comparability (similarity) to the reference product, supporting regulatory and clinical acceptance as a biosimilar.

Documents

GMP
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product